Enhanced anti-tumor effects using a combinatorial targeted treatment strategy in a preclinical model of prostate cancer

被引：0
|
作者：
Yamamoto, Yutaka [1 ]
De Velasco, Marco A. [1 ]
Hatanaka, Yuji [1 ]
Shimizu, Nobutaka [1 ]
Yoshimura, Kazuhiro [1 ]
Nozawa, Masahiro [1 ]
Kodama, Mitsumasa [1 ]
Yoshikawa, Kazuhiro [2 ]
Nishio, Kazuto [1 ]
Uemura, Hirotsugu [1 ]
机构：
[1] Kinki Univ, Sch Med, Osaka 589, Japan
[2] Aichi Med Univ Hosp, Nagakute, Aichi, Japan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2755
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2755
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A novel combinatorial approach using androgen receptor-targeted agents for treatment of prostate cancer
    Butler, Lisa
    Centenera, Margaret
    Marrocco, Deborah
    Carter, Sarah
    Bianco-Miotto, Tina
    Tilley, Wayne
    CANCER RESEARCH, 2009, 69
  • [32] Potent Anti-Tumor Effects of ApDCs (Aptamer Drug Conjugates) for Targeted Therapeutics in Pancreatic Cancer
    Yoon, Sorah
    Huang, Kai-Wen
    Habib, Nagy
    Rossi, John
    MOLECULAR THERAPY, 2016, 24 : S265 - S265
  • [33] ENHANCED ANTI-TUMOR EFFECTS OF ANTI-CTLA-4 ANTIBODY AND ANTI-PD-1 ANTIBODY TO KIDNEY CANCER MODEL IN MICE
    Motoshima, Takanobu
    Komohara, Yoshihiro
    Hasita, Horlad
    Kawano, Yoshiaki
    Wada, Yoshihiro
    Takeya, Motohiro
    Eto, Masatoshi
    JOURNAL OF UROLOGY, 2014, 191 (04): : E372 - E373
  • [34] Anti-tumor promotion with food phytochemicals: A strategy for cancer chemoprevention
    Murakami, A
    Ohigashi, H
    Koshimizu, K
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1996, 60 (01) : 1 - 8
  • [35] STRATEGY FOR ENHANCEMENT OF ANTI-TUMOR AGENTS EFFECTS ON HEMATOPOIETIC MALIGNANCIES
    OTA, K
    ACTA HAEMATOLOGICA JAPONICA, 1981, 44 (07): : 1245 - 1255
  • [36] Anti-tumor effects of engineered mesenchymal stem cells in colon cancer model
    Yang, Jianying
    Lv, Kui
    Sun, Junfeng
    Guan, Jianguo
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 8443 - 8450
  • [37] Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy
    Khan, Muhammad Muzamil
    Madni, Asadullah
    Filipczak, Nina
    Pan, Jiayi
    Rehman, Mubashar
    Rai, Nadia
    Attia, Sara Aly
    Torchilin, Vladimir P.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2020, 28 (28)
  • [38] Anti-tumor efficacy of the integrin-targeted immunoconjugate IMGN388 in preclinical models
    Vater, C. A.
    Manning, C.
    Millar, H.
    McCabe, F.
    Chen, Q.
    Anderson, G. M.
    Steeves, R.
    Lai, K.
    Lutz, R. J.
    EJC SUPPLEMENTS, 2008, 6 (12): : 167 - 168
  • [39] Active Immunotherapy With Prostvac® Demonstrates Potent Anti-tumor Efficacy in a Mouse Model of Prostate Cancer
    Rountree, Ryan B.
    Mandl, Stefanie J.
    Cote, Joseph
    dela Cruz, Tracy
    Giffon, Thierry
    Gordon, Evan
    Foy, Susan P.
    Lombardo, John R.
    Trent, Erica
    Laus, Reiner
    Delcayre, Alain
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 772 - 773
  • [40] Regulatory T cells contribute to suppression of the anti-tumor response in an immunotherapy model of prostate cancer
    Grant, J
    Ratliff, T
    FASEB JOURNAL, 2003, 17 (07): : C74 - C74
12345